Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which proceeds slowly and cannot be ...

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD)—the leading cause of kidney failure ...

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions ...

Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...

Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...

But what are the exact genetic pathways that make South Asians more prone to getting diabetes? And can insight into them help with better treatment? A new study by Sam Hodgson et al ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

This Diabetes Heart Connection Day we explore how management of diabetes and cardiovascular care often go hand in hand.